Drudge Retort: The Other Side of the News
Sunday, May 13, 2018

President Donald Trump delivered his long-awaited drug pricing proposal on Friday. The president, who once famously said pharmaceutical companies were "getting away with murder" on prices and often sent biotech shares tumbling with his harsh rhetoric, offered a number of policies meant to tackle the sky-high prescription drug costs borne by many in a plan dubbed "American Patients First." But most Trump's drug price reforms may largely spare the drug industry itself -- a possible reason that both S&P and NASDAQ biotech indices rose nearly 3% following the address. And a lack of specifics may have fueled 2% to 4% stock spikes for other health care companies like CVS, McKesson, and Express Scripts.

Advertisement

Advertisement

More

Alternate links: Google News | Twitter

It's also important to consider what the blueprint doesn't include -- such as a plan to allow Medicare to directly negotiate drug prices and establish a formulary, or permitting lower-priced drug imports from other countries.

Those were proposals loathed by the biopharma industry that Trump had previously floated; they didn't make it into Friday's speech, drawing a deep sigh of relief from the sector.

Comments

Admin's note: Participants in this discussion must follow the site's moderation policy. Profanity will be filtered. Abusive conduct is not allowed.

Trump got bought.

#1 | Posted by bored at 2018-05-12 12:12 PM | Reply

Trump just sold out (again) the public to big pharma. First with his tax scam. Now this.

Suckers.

#2 | Posted by 726 at 2018-05-12 04:41 PM | Reply | Newsworthy 3

Who could have foreseen a member of the 1% lyin his ass off and selling out the public for the 1%

Everyone but the rubes who got played by a snake oil salesman.

#3 | Posted by 726 at 2018-05-12 04:43 PM | Reply

Hey, it's just the Businessman Messiah being a businessman.

Anybody surprised at this point should call me, I've got a bridge for sale in Brooklyn.

#4 | Posted by jpw at 2018-05-13 04:11 AM | Reply

I like how the problem has been re-stated that other countries negotiate too much and get the prices too low.

This reminds me of the time Merck realized people on Vioxx were dying from heart attacks at 4x the rate of people on Aspirin. Merck presented these findings as "Aspirin 4x better at preventing heart attacks than previously thought."

#5 | Posted by snoofy at 2018-05-13 12:53 PM | Reply

How weak is President Trump's plan compared to obama's 'drug plan'?

Obama Reverses Stand on Drug Industry Deal
By DAVID D. KIRKPATRICKAUG. 7, 2009

WASHINGTON -- Caught between a pivotal industry ally and the protests of Congressional Democrats, the Obama administration on Friday backed away from what drug industry lobbyists had said this week was a firm White House promise to exclude from a proposed health care overhaul the possibility of allowing the government to negotiate lower drug prices under Medicare.

You can read the rest of the article here: www.nytimes.com

#6 | Posted by MSgt at 2018-05-13 01:33 PM | Reply | Newsworthy 1

Unfortunately, drug prices are a topic that I don't really think Hillary would have done much about either. Drug companies are significantly into pockets on both sides of the isle.

#7 | Posted by Whatsleft at 2018-05-13 02:08 PM | Reply | Newsworthy 1

Martin Shkreli says "I'm touching myself tonight".

#8 | Posted by ajwood at 2018-05-13 02:13 PM | Reply | Newsworthy 1

#6 Good job comrade.

#9 | Posted by 726 at 2018-05-13 02:32 PM | Reply

Thanks, now I know what to buy tomorrow.

#10 | Posted by phesterOBoyle at 2018-05-13 04:22 PM | Reply

But please, Trumpzombies, spin and deflect away.

#11 | Posted by e1g1 at 2018-05-13 10:56 PM | Reply

$AGN?

#12 | Posted by GOnoles92 at 2018-05-13 11:09 PM | Reply

How weak is President Trump's plan compared to obama's 'drug plan'?
Obama Reverses Stand on Drug Industry Deal
By DAVID D. KIRKPATRICKAUG. 7, 2009
WASHINGTON -- Caught between a pivotal industry ally and the protests of Congressional Democrats, the Obama administration on Friday backed away from what drug industry lobbyists had said this week was a firm White House promise to exclude from a proposed health care overhaul the possibility of allowing the government to negotiate lower drug prices under Medicare.
You can read the rest of the article here: www.nytimes.com
#6 | POSTED BY MSGT

Sorry Obama had to appease a few Conservative Democrats to get his much bigger plan through Congress.

What's Trump's excuse besides stupidity and being owned?

You've got Cheetos ---- on your nose again.

#13 | Posted by Sycophant at 2018-05-14 12:54 PM | Reply

Comments are closed for this entry.

Home | Breaking News | Comments | User Blogs | Stats | Back Page | RSS Feed | RSS Spec | DMCA Compliance | Privacy | Copyright 2018 World Readable

Drudge Retort